Read + Share
Amedeo Smart
Independent Medical Education
Kim JH, Ryu MH, Park YS, Ma J, et al. Predictive biomarkers for the efficacy of nivolumab as >/= 3(rd)-line therapy in patients with advanced gastric cancer: a subset analysis of ATTRACTION-2 phase III trial. BMC Cancer 2022;22:378.PMID: 35397540
Email
LinkedIn
Facebook
Twitter
Privacy Policy